The ecdysteroid agonist activity of 71 HPLC-purified ecdysteroids was measu
red in the Drosophila melanogaster B-II tumorous blood cell line assay. The
resultant log(ED50) values, spanning almost 6 orders of magnitude, were us
ed to construct a comparative molecular field analysis (CoMFA) model in whi
ch conformations were selected by homology to the crystal structure of ecdy
sone. Model A was constructed by utilization of the region-focused electros
tatic indicator field (q(2) = 0.631, r(2) = 0.903, 5 components, 4 outliers
). Model B made use of region-focused electrostatic and steric indicator fi
elds along with MlogP (q(2) = 0.694, r(2) = 0.892, 5 components, 4 outliers
). The model and its underlying bioassay data support a pharmacophore hypot
hesis in which ecdysteroid binding is understood to be due principally to t
he summation of localized interactions from approximately six specific loci
. This is in contrast to previous structure-activity relationship hypothese
s which are formulated in terms of the presence or absence of essential fun
ctional groups, without which ecdysteroid receptor affinity would be comple
tely absent. The present CoMFA model is utilized to predict the activities
of heretofore unknown ecdysteroids.